Nockolds Solicitors was approved as the new administrator of the ADR trial by RCVS Council at its June 2016 meeting at Cardiff City Hall. The company was identified and approved by the RCVS Operational Board as meeting its requirements, a decision which the RCVS says has been welcomed by the Veterinary Defence Society and the British Veterinary Association, as well as receiving lay and consumer support.
The current trial, which was launched in November 2014 and is administered by Ombudsman Services, will come to a close by 1 October, when the new trial with Nockolds will start.
Nick Stace, RCVS Chief Executive and Secretary, said: "In order to be able to make an informed choice about how we wish to design and implement a permanent ADR scheme we wanted to ensure that we have as many different options and as much data as possible. It is very important that we get the permanent scheme right and this is why Operational Board made the decision to have a second trial. It was also clear that satisfaction levels from consumers for the previous trial were lower than we would have liked and that we therefore need to explore other options.
"It is important to note that this will not just be a re-run of the first trial with a different administrator – there will be some significant differences between this and our first trial with Ombudsman Services.
"First, this will be a truly alternative process as consumers will be able to access the trial directly rather than having to go through the College’s concerns process first.
"Second, this will be a process of mediation meaning that expert advisors from Nockolds will facilitate communication between the complainant and the veterinary surgeon to try and find a satisfactory solution to the concern."
The trial will be promoted to both the public and the profession as an alternative to the College’s formal concerns investigation process and participation in the trial will be voluntary. There will also still be a panel of veterinary advisors overseeing the trial and helping staff at Nockolds with any clinical queries they may have.
Jennie Jones is a Partner at Nockolds and will head up the trial. She said: "We are committed to providing a service that mediates complaints to find a fair, efficient and proportionate resolution. We are looking forward to working with everyone involved in veterinary profession to develop an effective mediation service that can be accessed by both the public and members of the profession.
"The service will focus on finding effective and practical resolutions. Understanding the root cause of the complaint and re-establishing effective communication are the crucial first steps in mediation and helping the parties to find a solution they can both accept. Over the coming months, we will be working with the RCVS, representative bodies for the profession and consumers to launch the service.
"In addition to mediating complaints, we will share insight in mediation and complaint resolution to inform practitioners and stakeholders and to enhance standards at veterinary practices. This enables complaint analysis to be used to help improve client care, avoid complaints and maintain trust and confidence in the profession."
A bespoke website for the trial will be set up in time for the launch on 1 October 2016.
The new bars are designed specifically for owners who want a sustainable choice. They contain no harmful preservatives or foaming agents and are SLS and parabens free. Sue says that all the ingredients in the soaps have been selected to minimise their environmental impact and help maintain a healthy skin and coat.
Sue said: "Dog owners are environmentally conscious and recognise that in addition to their own carbon footprint their furry family member also has an important part to play when it comes to sustainability."
Apparently, Zurich’s Institute of Environmental Engineering has shown liquid soap has ten times the carbon footprint of bar soap: bottles need more energy and water to produce them, they are less efficient to transport, and many contain synthetic chemicals which can cause damage to the ecosystem if they get into water sources.
Sue added: “We need to make the same sustainable choices for our pets as we make for ourselves. One shampoo soap bar is the equivalent of two bottles of shampoo so they are not only good for the planet they are great for your pocket as well. It makes it easy for pet owners to make the right choice and reduce their pet’s carbon footprint without compromising on their care.”
For more information visit: https://virtualvetderms.com/login/product/antibacterial-shampoo-bar or https://virtualvetderms.com/login/product/soothing-shampoo-bar.
The BVA has paid tribute to Lord Ballyedmond, founder of the veterinary pharmaceutical company Norbrook Laboratories, after he was killed in a helicopter crash in Norfolk last Thursday.
The life peer (pictured second from left collecting a business award in 2011) founded Norbrook over 40 years ago. It became one of the biggest manufacturers of animal health products globally, and now employs more than 1000 people. Dr. Edward Haughey, as he was previously known, was ennobled in 2004.
Following his death, Norbrook issued the following statement:
"It is with sincere sadness and deep regret that the Company confirms our founding Chairman and CEO, Lord Ballyedmond, was one of four people who tragically lost their lives in an aviation accident at Gillingham, Norfolk at approximately 7.30pm on Thursday 13 March 2014.
Norbrook management and staff also mourn the loss of their friends and colleagues Declan Small (Site Foreman), Captain Carl Dickerson (Pilot) and Captain Lee Hoyle (Pilot).
Our thoughts are with the immediate families and friends of the deceased who have requested privacy at this difficult time.
We take enormous pride in our Chairman's extraordinary legacy in establishing Norbrook as a global veterinary and pharmaceutical industry leader. Management will continue to advance his pioneering vision with a renewed vigor and determination befitting his memory."
BVA President Robin Hargreaves said: "We are deeply saddened to hear of the tragic passing of Lord Ballyedmond. He has been a great supporter of the veterinary profession and of BVA, and made an enormous contribution to veterinary medicine. He built opportunity for thousands of people in Northern Ireland and around the world and had a huge commercial and industrial presence throughout my whole career. Above all Lord Ballyedmond was a family man and all our thoughts are with his wife and children at this time."
Richard Casey, President of The Veterinary Marketing Group (VMG) said: “Pegasus’s survey has shown some very encouraging results. But it is also very worrying that so many of our colleagues do not feel safe from COVID19 exposure in the workplace.
"I encourage all our colleagues, regardless of whether they are management or not, to reach out to workplace colleagues. Ask them how they’re feeling, what are their concerns and what is working well?
"The same goes for clients. Let’s not assume that because we’re not yet fluent in consulting virtually that the client doesn’t value the flexibility of hearing your expert voice from the comfort of their home.
"Instead, invite feedback on how your new approaches are landing. What could be done differently? The key to managing anyone’s expectations is always clear communication. Even more so in today’s consumer driven, 24/7 economy. The veterinary practices who come out of COVID-19 well, will likely be the ones who embrace the new normal. They’ll have listened to their team and clients needs, and found ways to meet them.”
The new scanner takes scans 50% faster and at a far higher resolution than the outgoing model.
It also boasts a wide bore magnet, simple coil arrangement and large number of channels, which means clinicians can scan different organ systems in patients of all shapes and sizes.
Cave says the new equipment allows it to expand into emerging fields such as cardiac MRI and advanced musculoskeletal imaging.
Tom Cardy, head of neurology, said: “It’s not often in your career you get to work with a truly class-leading piece of equipment such as this.
“The new scanner will greatly improve the patient and client experience we provide. This investment significantly increases the capability of our neurology service and the whole team are excited to get to grips with this amazing piece of kit.”
For more information, visit https://cave-vet-specialists.co.uk.
Photo: L-R Radiographer Tracy Down and imaging nurse Staci Finn
The decision was made after Council heard increasing reports that practices have not been keeping records of POM-V parasiticide prescriptions within patient records as has always been required by the VMD.
This created a bit of a problem when the new 'under care' guidance came into force at the start of this month, which requires that veterinary surgeons must perform a physical examination as part of their initial clinical assessment of an animal before prescribing POM-V anti-parasitics.
Failing a record of an existing prescription, that would have meant re-examining large numbers of animals at a time when resources in the profession are already stretched.
RCVS President, Sue Paterson, said: “While it has been both surprising and disappointing to learn of such widespread non-compliance with legislation that has been in place for many years, Council decided to postpone the implementation of this one aspect of our new under care guidance to allow practices additional time to bring their prescribing protocols into line."
The delayed implementation date of 12 January 2024 relates only to the prescription of POM-V anti-parasitics.
The rest of the new under care guidance remains in effect from 1 September 2023
The updated indications reflect the recognition that Stelfonta may be used in any case where surgery may not be an option:
For the treatment of non-metastatic (WHO staging) mast cell tumours that are either non-resectable or those that are resectable but where surgery is not considered the best option, specifically: cutaneous mast cell tumours (located anywhere on the dog) and subcutaneous mast cell tumours located at or distal to the elbow or the hock.
Tumours must be less than or equal to 8 cm 3 in volume, and must be accessible to intratumoral injection.
Neil Mottram MRCVS, Technical Manager at Virbac said: “Stelfonta offers veterinary surgeons a medical option for the successful elimination of mast cell tumours.
"The extended labelled indication demonstrates the wide variety of cases that can benefit where medical treatment is preferred, such as; tumour factors (location and size) making surgical margins difficult, patient factors (concurrent disease and risk of anaesthesia), clinic factors and the simplification of this medical treatment and owner factors, where there is a preference to avoid surgery."
Stelfonta is administered by injection directly into the tumour mass and Virbac say that generally, dogs do not require sedation or local or general anaesthesia during treatment.
The active ingredient, Tigilanol tiglate, works largely through specific protein kinase c (PKC) activation, in which it locally stimulates the immune system, resulting in destruction of the tumour and the tumour’s blood supply, followed by rapid healing of the site with minimal scarring.
www.virbac.co.uk
Vetoquinol UK has launched Dolpac®, its new wormer for dogs.
Dolpac® is a broad spectrum anthelmintic for dogs containing pyrantel, oxantel and praziquantel. Individually these ingredients are effective against individual worm species and the combination of all three provides specific activities against the most common roundworm and tapeworm species.
According to the company, clinical studies carried out in accordance with internationally recognised guidelines have shown that Dolpac® provides an excellent ability to reduce parasitic infection.
“Dolpac® offers vets and their clients an easy to use worming alternative at an affordable price,” explains Mark Leddy, Vetoquinol’s Marketing Department Manager. “Our aim is to help to increase the number of dog owners worming their pets at the correct frequency, which will not only protect their dogs, but their children as well. We have introduced a number of features to help achieve this objective, there are three tablet sizes to cover all weight ranges and the tablets are flavoured and easy to give, and there are dispensing envelopes in every pack. We also provide a dosing wall chart and a client worming guide.”
For more information, contact your Vetoquinol representative or visit the Dolpac website, http://www.dolpac.co.uk/, which offers information for both vets and clients.
The change to the Practice Standards rules means that RVNs who have at least five years’ experience within the profession are eligible to apply to become PSS Assessors.
PSS Assessors are employees of the RCVS who are responsible for visiting practices that want to join the scheme, are undergoing their re-accreditation assessment or have applied for one or more of the PSS Awards, to ensure they meet the criteria.
The decision to allow RVNs to become PSS Assessors had already been approved by both the Practice Standards Group (the steering committee for the Scheme comprising representatives from all of the major veterinary and veterinary nursing organisations in the UK) and the RCVS Standards Committee.
Matthew Rendle is the Chair of VN Council and also sits as a member of RCVS Council. He said: “I am delighted to see that there is now a pathway to recruit veterinary nurses as PSS Assessors and hope that many of my VN colleagues will take up this opportunity to apply to join the excellent team responsible for ensuring that the Scheme’s stringent standards are met.
"We know that, on a practice-by-practice basis, veterinary nurses often play a big role in helping to coordinate and ensure that the requirements of the Practice Standards Scheme are met, for example, by preparing their team for the assessment, liaising with the RCVS and the Assessor and making sure all standards are complied with in advance. It is great to see that the crucial role they often play in meeting standards is reflected in opening up the ability to become PSS Assessors."
Mandisa Greene, RCVS President and Chair of the Practice Standards Group, added: “This is such an important development for the veterinary nursing profession whose role in the Practice Standards Scheme has long been recognised as invaluable. This decision also opens up new career advancement opportunities for the profession as well, which I’m sure is very welcome."
When the next recruitment round for PSS Assessors takes place, RVNs will be invited to apply to join the roster of Assessors.
In addition to approving the role of RVNs as PSS Assessors, Council also approved a new Equine Emergency Services Clinic accreditation to help incorporate the emerging business model of veterinary practices that provide ambulatory emergency services for equids.
The new accreditation would require these practices to meet the applicable PSS Core Standards, plus the requirements contained in an additional Equine Emergency Services module. The full details of the requirements will be published in due course.
For more information about the Practice Standards Scheme visit: www.rcvs.org.uk/pss
The Disciplinary Committee took the unusual step of granting an application by the respondent for anonymity, after seeing evidence of a real and immediate threat to the individual’s security if their details were made public.
For the purposes of the hearing, the respondent was therefore referred to as 'X'.
The Committee heard that the individual pleaded guilty in court in 2020 to intentionally and knowingly attempting to communicate with a person under 16 years for the purposes of sexual gratification.
Following this they were sentenced to a two-year probation order, were ordered to register on the Sexual Offences Register for five years; and were made subject to a Sexual Offences Prevention Order for five years.
At the outset of the hearing the individual admitted to all the charges against them and the Committee also noted that there was a certified copy of the conviction available.
The Committee then considered whether the conviction amounted to serious professional misconduct. In considering this, it set out the aggravating factors surrounding the case, these being that there was the risk of actual harm to a minor, that the misconduct was premeditated as the respondent had sent a number of messages via a number of online platforms over several days, that the individual displayed predatory behaviour including sending pictures and making comments of a sexual nature, and that it involved what the respondent believed to be a vulnerable individual, namely a 15-year-old child.
In mitigation, the Committee considered that there had been no actual harm caused to a human or animal in light of the fact that the 15-year-old child, who the respondent believed they were communicating with, was not real. It also took into account that the conduct related to a single isolated incident and that the individual had made open and frank admissions at an early stage.
Cerys Jones, chairing the Committee and speaking on its behalf, said: “The Committee was satisfied that the sentence imposed on X, which included X being subject to a Sexual Harm Prevention Order until 2025, resulted in the profession of veterinary nurses being brought into disrepute and, in the Committee’s judgement, public confidence in the profession would be undermined if the Committee did not find that the conviction rendered X unfit to practise as a veterinary nurse.”
In considering the individual’s sanction, the Committee heard from a character witness who said that the respondent’s actions were out of character, that they had a previously long and unblemished career, that they had made full admissions and demonstrated insight, and that they had a low risk of reoffending in the future.
Cerys said: “The Committee accepted that X had been an excellent veterinary nurse and that X’s criminal conduct did not relate to X’s practice as a veterinary nurse. However, in the Committee’s judgement, the aggravating factors outweighed the considerable mitigating factors in this case.”
She added: “The Committee decided that a suspension order was not the appropriate sanction for such a serious offence because it did not reflect the gravity of X’s conduct. In the Committee’s judgement, the wider public interest, that is the maintenance of the reputation of the profession and the College as a regulator, required a sanction of removal from the Register. The Committee considered that X had much mitigation and was clearly a dedicated veterinary nurse but the reputation of the profession was more important than the interests of X.
“Further, the Committee noted that in circumstances where X’s probation order expired in 2022, and where the ancillary orders, a Sexual Harm Prevention Order and a requirement to register on the Sexual Offences Register did not expire until 2025; the only proportionate sanction was to direct the Registrar to remove X’s name from the Register of Veterinary Nurses.”
The full findings for the case can be found at: www.rcvs.org.uk/disciplinary
Zoetis has announced that the European Commission has granted marketing authorization for Simparica™ (sarolaner) chewable tablets, a once-monthly medication for the treatment of fleas, ticks and sarcoptic mange in dogs beginning at eight weeks of age.
Dr. Balázs Capári, a Hungarian veterinary specialist in small animal medicine who participated in clinical trials of Simparica said: "The approval of Simparica gives veterinarians a new oral choice in parasite control for dogs. In my experience, Simparica has been shown to rapidly kill fleas and ticks with efficacy that persists for five weeks. Dog owners participating in the trials also reported that Simparica is very palatable; the chewable tablet was easily taken by their dogs. The convenience of a once monthly chewable tablet helps increase compliance with treatment, giving veterinarians and dog owners confidence in continuous protection."
Dr. Catherine Knupp, Executive Vice President and President, Research and Development at Zoetis, said: "At Zoetis, we focus our innovation on the most pressing needs of veterinarians, and that is what guided us to develop a new oral choice to provide dogs with persistent protection from fleas and ticks and treatment of mites that cause sarcoptic mange. Simparica is a result of the collaboration of Zoetis scientists worldwide, who share a determination to develop new medicines that deliver real value to our veterinary customers and the animals in their care. We are excited to bring this innovative medicine, Simparica, to veterinarians and dog owners across Europe."
The active substance of Simparica is sarolaner, a new ectoparasiticide in the isoxazoline class, developed by Zoetis.
Zoetis says the marketing authorization for Simparica was based on the results of field studies conducted in seven countries, involving more than 800 dogs of various breeds from at least eight weeks of age and 1.3 kg of weight. Simparica was shown to provide efficacy for at least five weeks against ticks and fleas. It demonstrated a rapid onset of action, killing fleas before they have a chance to lay eggs and can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis. It proved effective in treating sarcoptic mange, a highly contagious skin disease in dogs.
In studies, Simparica killed all four species of tick dominant in Europe (Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus and Rhipicephalus sanguineus) and species of flea that most frequently infect dogs in European countries (Ctenocephalides felis and Ctenocephalides canis). Simparica was well tolerated with no adverse events reported at the therapeutic dose.
Zoetis expects to launch Simparica in the EU in the first quarter of 2016. Simparica chewable tablets will be available in 5mg, 10mg, 20mg, 40mg and 80mg dosage strengths.
For more information about Simparica and full prescribing information, visit http://www.zoetis.com/products-services/companion-animals/dogs.
The kit contains the ergonomically designed Henke-Sass Wolf injector with an adjustable dose selector, five single piece Intranasal RSP nozzles – with ‘luer’ lock attachment, which supports easier removal, cleaning and/or replacement – and instructions for use.
For more information, contact your local MSD Animal Health account manager.
The definition agreed by VN Council is as follows:
Veterinary nursing aims to ease the suffering and pain of animals, and to improve their health and welfare.
This includes providing any medical treatment or any minor surgery (not involving entry into a body cavity) to animals under the direction of a veterinary surgeon who has that animal under their care.
Veterinary nursing can be either proactive or reactive, and autonomous or collaborative. It is carried out in a wide variety of settings, for animals at all life stages, and considers the background and needs of the animal’s owner or keeper.
Matthew Rendle RVN, the Chair of VN Council, said: “Although it is just a few short lines, this definition of veterinary nursing has been in the pipeline for some time.
"While we as veterinary nurses have always been able to define ourselves by the type of tasks we carry out, or our relation to veterinary surgeons in terms of delegation, there hasn’t necessarily been a clear statement articulating the art and science of veterinary nursing.
“With the RCVS looking to expand its regulatory remit to include other veterinary paraprofessionals over the long term, we thought it was particularly important that we set out the stall for veterinary nursing and we hope that this clear statement will, in particular, aid the public in understanding the role of a veterinary nurse.
“It should be noted that this definition is VN Council’s own considered interpretation of the art and science of veterinary nursing.
"Other interpretations from other organisations, provided they conform with both Schedule 3 of the Veterinary Surgeons Act and the RCVS Code of Professional Conduct, could sit comfortably alongside ours, and we hope there continues to be healthy discussion about the contribution of the profession to the veterinary team, as our role evolves.”
The company says the like-for-like sales increase was at the upper end of its target of between 4% and 8%, and that it continues to see resilience in the veterinary sector, with membership of its Healthy Pet Club preventative healthcare scheme increasing in the year by 19,000 members (an increase of 4.0%) to 489,000.
CVS says its Board decided to enter the Australian marketplace because of its low levels of corporate consolidation, favourable market dynamics and strong similarities with the UK, including highly trained veterinary surgeons, shared language and culture, and the group's experience with UK vets working between Australia and the UK.
Earlier this month, the group signed agreements for the conditional acquisitions of four independent small animal first opinion veterinary practices in Australia: two in Brisbane, one in Queensland and one in Sydney, for an initial consideration of £16.8M.
Two of the acquisitions have now been completed, and the other two are expected to be completed shortly.
The company says it now plans to acquire more Australian practices in major urban conurbations, including Sydney, Melbourne, Brisbane, Perth, Canberra, Newcastle and Adelaide.
Ben Jacklin, Deputy CEO said: "Having worked as a vet in Australia earlier in my career, I know well their high standards of clinical care, and the dedication of highly talented veterinary professionals that work there.
"As a company dedicated to giving the best possible care to animals, I see a fantastic opportunity for us to enter this growing market, with low levels of corporate consolidation, and execute our vision of being the veterinary company people most want to work for.
"I have spent time in Australia over the last 12 months, including meeting some fantastic veterinary practices, and it is clear we have a significant opportunity.
"With the four outstanding practices that are joining us, and a strong pipeline of further acquisition opportunities, I am excited to build a significant CVS business in Australia with the same culture and values that have brought us success in the UK."
The course was developed with RCVS Leadership and Inclusion Manager, Gurpreet Gill (pictured), and aims to increase self-awareness of unconscious bias, explore strategies to reduce it, and promote equity, diversity, and inclusion in the workplace.
Gurpreet said: “Unconscious bias is an area that some within the professions may not be familiar with and so this course provides an overview of unconscious bias and its impact in the workplace.
“We also explore strategies that we can all apply to help reduce unconscious bias.
"This is important in helping to achieve fairer and more equitable working environments, and I’d encourage any veterinary professional, whatever your role, to undertake the course.”
The course is accessible free via the RCVS Academy, and takes about an hour and three quarters to complete,
Building on the unconscious bias course, the RCVSA academy has also launched a course for members of the Fellowship Credentials Panels, who are responsible for assessing applications to the Fellowship.
Dr Niall Connell FRCVS, Acting Chair of the Fellowship Board, the governing body for the learned society, said: “This course explores the complexities of assessing applications, ensuring that each candidate receives a fair and thorough evaluation.
"Participants will gain insights into best practices for reviewing applications, offering constructive feedback, and identifying and addressing potential biases that may influence decision-making.
"By completing this course, participants will gain a heightened proficiency in assessing applications and managing bias, enabling them to support the RCVS’ mission of fostering equity, diversity and inclusion within the Fellowship.”
https://academy.rcvs.org.uk
For the study, 12 month's worth of anonymised data from CVS practices was analysed2.
The study concluded that lower engagement between a practice and its staff or clients, recent parental leave, shorter practice employment tenure, and younger age were all associated with an increased likelihood of support staff resignations.
Lower practice client engagement, which CVS says is a proxy for client satisfaction, was associated with increased odds of support staff resigning3, highlighting the potential impact of client incivility on veterinary colleagues who are typically in customer facing roles.
Reduced employee engagement – measured by a ‘employee net promoter score’ (eNPS), where colleagues rate how likely they would recommend the practice as a good place to work4, also correlated with increased resignations.
Within CVS, eNPS has been demonstrated to be positively correlated with the frequency of line manager discussions.
The current data suggests that consistent measurement of employee engagement in a veterinary setting at regular intervals throughout the year can have benefits for line managers in identifying increases in the risk of resignations and practice attrition, allowing them to take proactive steps to improve engagement.
A recent record of taking parental leave was also associated with greater odds of resigning in the following 12 months than staff who have not taken parental leave in the previous 12 months5.
Qualitative studies in other professions highlight the need for greater flexibility in working hours and focused managerial check-in support.
Therefore ‘return to work’ interventions may present an opportunity to improve retention.
Conversely, the increased length of employment tenure was associated with decreasing odds of support staff resignations6, potentially highlighting the role for long service reward schemes, such as the long service holiday awards CVS introduced a couple of years ago. Whilst employee age was associated with the odds of resignations, with a 1% decrease in the odds of support staff resigning with each additional year of age7.
Imogen Schofield, Director of Clinical Research at CVS, said: “Support staff are integral members of the team.
"These key roles contribute to the efficient and effective functioning of a veterinary practice.
"Despite the important roles of support staff, little research exists on these team members and there is no data describing reasons for their attrition.
“This research was done to help the wider industry to understand how we can reduce support staff resignations.
"It aims to identify demographic, payroll and engagement factors associated with resignations.
"We believe it adds valuable insights to previous survey-based research by organisations such as the British Veterinary Receptionist Association.
“Reflecting on our research from 2021, we have introduced a Zero Tolerance Policy to protect our colleagues against intrusive, offensive, violent or aggressive behaviour from clients.
"We have launched monthly interactive Receptionist Support Sessions, giving receptionists the opportunity to connect with their peer network, share experiences and ideas, and feel supported.
"And we are now focussing on developing our support staff through creating new Receptionist and Patient Care Assistant Career Pathways.”
References
However, when asked by VetSurgeon.org which audience - veterinary professionals, it's staff or the public - it was referring to, or what threats to safety and wellbeing were posed by X, the College refused point blank to answer.
So the real motivation remains unclear.
On the one hand, it could be a ridiculously over-sensitive move to protect its unknown audience from opinions that its staff find objectionable.
On the other hand, it could perfectly well be argued that short form social media reduces every discussion or debate to "I'm effing right and you're effing wrong", which is not appropriate for a scientific profession.
Equally, one could also argue that engaging in polarised debate online is not terribly good for one's wellbeing.
Or one could just argue that it's a terrible platform owned by a strangely meddlesome and interfering American.
However, given the College's strange refusal to expand on the reasons for its withdrawal, the first explanation seems more likely.
But who knows?
https://www.rcvs.org.uk/news-and-views/news/rcvs-statement-on-x-formerly-twitter/
Researchers at the University of Saskatchewan's Western College of Veterinary Medicine (WCVM) are carrying out a survey of equine practitioners to discover, amongst other things, just how common Cushing's disease is internationally.
The 16-question survey was launched this month and will be available for a further six months at www.wcvm.com/veterinarians/cushings_survey.php
Dr. James Carmalt, an equine surgeon and associate professor in the WCVM's Department of Large Animal Clinical Sciences said: "Our objective is to determine the true prevalence of Cushing's disease worldwide, because until now, previous surveys were only based in the U.S."
Dr. Carmalt is also a PhD student in equine neurophysiology through the western Canadian veterinary college's Department of Veterinary Pathology. He and his graduate supervisor, veterinary pathologist Dr. Andrew Allen, are beginning to explore a new treatment methodology for equine Cushing's disease.
Researchers will use practitioners' responses to the brief survey to determine the incidence of the disease and the most common treatment protocols being used by practitioners in countries around the world. They also want to evaluate the need for developing new treatment methodologies. Dr Carmalt said: "Right now, the only available treatment for Cushing's disease requires daily dosing of medications for the rest of the horse's life. It's onerous, time consuming and a huge management challenge.
"If the responses from this survey reflect our impression that practitioners need a new option to offer their clients, our ultimate goal is to develop a one-time treatment for the disease so daily medications for Cushing's disease become unnecessary."
For more information about the Cushing's disease survey for equine practitioners, please contact Dr. James Carmalt (james.carmalt@usask.ca). As part of the survey, practitioners can also provide their email addresses if they wish to receive a copy of the survey results.
New research from the Animal Health Trust (AHT), published in the Equine Veterinary Journal, shows that equine obesity is an increasing but under-recognised welfare issue in the UK.
Data collected from 785 horses and ponies (31% of which were classified as obese), over a two-year period between 2009 and 2011, has been used to explore various elements that contribute to the risk of obesity in British horses and ponies.
The research, funded by World Horse Welfare, identified several factors which may increase the risk of being obese. Pony breeds, particularly UK native breeds and heavier horses such as draught and cobs types were all significantly more likely to be obese compared to Thoroughbred horses. Charlotte Robin, Research Assistant at the AHT and lead author of the paper, said: "Native breeds may be genetically better adapted to survive in harsh conditions, having a so-called thrifty genotype, increasing their risk of obesity when maintained in an environment where food is of better quality and more readily available."
Horses that were described by their owners as readily being able to gain weight or being "good doers" were more than three times more likely to be obese, compared to those that normally maintained weight.
The research also highlighted various links to human obesity. Charlotte said: "In humans, obesity is associated with poor health status and chronic health conditions including diabetes, hypertension, respiratory disease and arthritis. Similar associations between obesity and adverse health events have been described in equines."
Similarly in humans, exercise significantly improves insulin sensitivity, and it is thought the same "dose-response" effect is mirrored in horses. For example, the AHT's research highlighted that the risk of obesity is greater in pleasure or non-ridden horses, with pleasure horses being more than twice as likely to be obese and non-ridden horses being nearly three times more likely to be obese. Competition animals will receive increased exercise at a higher intensity and be fitter than non-competition animals, further reducing the risk of obesity. Charlotte added: "Competition horses are likely to be managed in different ways compared to non-competition or non-ridden animals and this may also contribute to the reduced risk of obesity within this sub-population."
World Horse Welfare's Deputy Head of UK Support, Sam Chubbock said: "Excess weight is one of the greatest challenges facing horse owners in the UK today, which is why we supported this vital research. Being overweight can be just as much, if not more, of a health concern as being underweight. In our experience it can take three times longer to get an overweight horse back to optimum condition than it can a thin horse. Moreover, a previously obese horse's weight will need to be managed for the rest of its life, even after the weight has come off, and they are likely to suffer long-term effects. Managing a horse prone to weight gain can be incredibly difficult and this is why our Right Weight project provides practical guidance for owners on how to assess and manage their own horse's weight."
The AHT says its obesity research has helped to highlight obesity as a significant equine welfare issue and provided valuable information for owners. People frequently misclassify their own weight or body shape, and this phenomenon also applies to perceptions about our pets' weight. Dog and horse owners have been demonstrated to underestimate their animals' weight, suggesting the prevalence of obesity in this study is likely to be an underestimation.
Charlotte said: "It is possible that in certain breeds, being overweight or obese has been normalised to a certain extent. Owners may find it easier to identify an overweight Thoroughbred, compared to an overweight cob or native pony.
"Helping owners identify when their horse is overweight or obese is an essential aspect of reducing the welfare impact of equine obesity."
Reference
The Working Group, which was formed in January, is chaired by Nigel Gibbens (pictured right) and composed of representatives from BVA specialist divisions and affiliate groups, and others with relevant expertise and knowledge.
As the Association says, the RCVS review will potentially have a far-reaching impact on the future of the veterinary profession, animal health and welfare, and the relationships vets have with their clients.
Of particular concern are the impact of remote prescribing on animal welfare and how limited-service providers (ie those offering online consultations only) will affect the commercial viability of full-service providers.
It is therefore hugely important that the BVA's response represents the opinions and evidence of as many people in the profession as possible.
Information about the BVA Working Group, including the minutes of meetings held so far and the 'themes' document which reflects the group's current thoughts, can be found here: https://www.bva.co.uk/about-us/our-structure/working-groups/
Nigel said: "I encourage you to look at this information carefully, and feed in any evidence that you wish the group to consider along with your thoughts on the content of the BVA response to the RCVS. You can do this via BVA’s Head of Policy & Governance Amelia Findon (ameliaf@bva.co.uk) who will ensure that comments are collated and considered by our group.
"The breadth of opinion across the profession means that the BVA response cannot please everyone, nor should it attempt to. However, it will be based on available evidence and a good understanding of the full scope of views. BVA policy will thus reflect the majority view whilst embracing the positive potential of technological innovations that will inevitably change the way we interact with clients. I urge you to take the time to consider the implications and let us have your thoughts."
Suffolk veterinary surgeon Gerhard Putter is appealing for support for a gala evening on 14th March 2015 to raise funds for a bucket list set up by his colleague, vet Lisa Milella, who has been diagnosed with incurable Motor Neurone Disease.
Lisa, one of the world’s few specialist animal dental surgeons, has volunteered for charity International Animal Rescue (IAR) for many years. She is also a trustee of the charity. During her time working with IAR, she has worked in countries including India and Indonesia, treating animals including abused bears, orangutans and slow lorises, which have suffered cruelty at the hands of humans. Now, as her health deteriorates, she is unable to work herself, but she is devoting her remaining time to fundraising for IAR to ensure her work can continue when she is no longer here.
Gerhard, who works at the Mulbery Court Veterinary Centre in Sudbury and is also a specialist veterinary dental surgeon, has worked with Lisa many times. He is now hosting the gala evening at Stoke by Nayland Golf Club to support her fundraising efforts. Tickets cost £25.00 per person and include a buffet, entertainment, raffle and other attractions.
He said: "Lisa helped 'dancing bears' which had had their teeth knocked out with iron bars to make them easier to control; slow lorises which had their teeth clipped off by illegal traders before being sold as pets and even orangutans, which are sometimes beaten by their captors, leaving them with broken teeth and bruises. I've seen at first-hand how important her work is and have worked with her on a number of volunteer projects.
"Her diagnosis with MND is a terrible personal tragedy for her but she is focusing on the positive and trying to do what she can for these animals while she still can. The teams at Mulberry Court and the All Animal Dental Centre are determined to support her but the success of our Gala Evening depends on the generosity of people willing to support Lisa’s Mission to raise as much money as possible.
"We hope everyone will get behind us and buy tickets. We would also welcome gifts for our raffle and any other offers of help."
For more information, please email Gerhard Putter, at Mulberry Court Vet Surgery, allanimaldentalcentre@gmail.com or contact him on 01787 881888.
Dr. Lauren Finka, a researcher at the University of Lincoln, has developed L-CAT, a new tool for assessing behaviour in cats at rehoming centres and help match them to the ideal new home.
During the course of her PhD studies, which were part funded by COAPE (Centre of Applied Pet Ethology), Lauren discovered inconsistencies in the current models and perceptions of behaviour traits used in re-homing cats.
For example, one of the most common behaviours associated with affection towards humans is the activity of rubbing. Initial results suggested that this is often very inconsistent, as are several other behaviours that were previously thought to to be important in assessing a cat's underlying temperament. Dr Finka’s studies showed that it all depends much more on the specifics of the physical and social context of interactions and that these may change on a daily basis. It was found that on one day a cat might rub against a person ten times, but the next day rub against the same person only once.
The Lincoln Cat Assessment Tool (L-CAT) was developed during this research. COAPE says it is the first of its kind to offer a suitably robust, reliable and easy-to-use way of assessing behaviour in cats at re-homing centres, as well in predicting new owner satisfaction based on those assessments.
The organisation goes on to say that the potential welfare implications of this research are substantial, enabling cats to be properly but rapidly assessed, optimally managed, and suitably matched with would-be owners and thus shortening the length of time cats might spend in the re-homing centre.
L-CAT was tested to establish the possibility of predicting the future behaviour of cats after they had been adopted, as well as gauging how satisfied owners were likely to be with their cats. COAPE says the results generally confirmed that these outcomes were indeed possible, meaning re-homing staff could also use L-CAT to help manage the expectations of owners and potentially improve their satisfaction.
For more information, visit: www.coape.org
Douxo Care Auricular Lotion can be used for routine ear cleaning and removal of ear wax and as an ear cleaner prior to treatment in order to clean the ear canal of debris. Ceva says it is fast drying and pleasant to use and the lotion can also be adapted for the routine cleaning of skin folds and around the eyes.
Andrew Fullerton BVSc (Hons) MRCVS, Douxo product manager at Ceva Animal Health, said: “Following requests from dermatologists to launch this product in the UK, we are very excited to add Douxo Care Auricular Lotion to the UK Douxo range. It will provide a gentle yet effective and soothing option for dogs and cats needing regular ear cleaning and all under the Douxo brand we know and love.”
To support the launch of Douxo Care Auricular Lotion, the company is running a buy one, get one free offer (used once and up to a maximum of five units ie pay for five and receive five free of charge). For information on the offer, which runs until 31 October, contact cevauk@ceva.com, use the offer QR code or call 01494 781510 to request an order form or to process an order.
For more information, contact cevauk@ceva.com, call 01494 781510 or visit www.douxo.com/uk.
Amanda Melvin, Marketing Manager for the Companion Animal Team at MSD Animal Health said: "Research has shown that up to 20% of diabetic pets die, or are euthanised, within a year of diagnosis1 so we want to do everything we can to prevent any further increases in this figure.
"Recent circumstances have put most practices under a great deal of strain and it's become clear from the increase in calls we're receiving that there is a high demand for more information and resources to support the care of diabetic pets.
"We've therefore decided that with Pet Diabetes Month in November, our best way of supporting veterinary practices is to make them aware of, and know how to access the resources we have available to help them."
The diabetes resources include veterinary nurse clinics and training, getting the most out ofVetPen, monitoring support tools and case advice.
Veterinary professionals can subscribe for access to the materials as individuals or as a practice team.
For further information, visit https://www.msd-animal-health-hub.co.uk/ahp/caninsulin/tools.
Enalees offers a variety of point-of-care isothermal PCR animal diagnostics tests for canine, feline and equine infectious diseases, including parvo, leptospirosis, babesiosis and borreliosis.
The company says its tests are highly specific and sensitive and can detect the presence of a virus, parasite or microbe at a very early stage, without the use of expensive and complex equipment, within 30 minutes.
Lauren Craig is the General Manager of the new subsidiary. She said: “I will be coordinating the launch of the UK subsidiary and working with veterinary professionals to deliver Enalees’ unique portfolio offering in diagnostic testing and in clinic rapid PCR tests.
“I am incredibly excited for the challenge ahead and looking forward to working with a fantastic team with an important mission in this key market.”
www.enalees.com